| Literature DB >> 34422623 |
Jing Li1, Chao Ma1, Yukun Chen1, Caixia Fu2, Xinrui Wang1, Bernd Kuehn3, Qingsong Yang1, Jianping Lu1.
Abstract
PURPOSE: To investigate the feasibility of a fast liver magnetic resonance imaging (MRI) protocol for lesion detection in adults using 3.0-T MRI.Entities:
Keywords: Fast; MRI; auto; liver; workflow
Year: 2021 PMID: 34422623 PMCID: PMC8371706 DOI: 10.3389/fonc.2021.586343
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Clinical characteristics of the patients.
| Admitting diagnosis/medical history | No. of cases (%) |
|---|---|
| Intestinal neoplasms | 13 (41.9) |
| Hepatic mass | 2 (6.5) |
| Hemangioma | 1 (3.2) |
| HCC | 9 (29.0) |
| Carcinoma of gallbladder | 1 (3.2) |
| Pelvic mass | 1 (3.2) |
| Gastric carcinoma | 3 (9.7) |
| Pancreatic cancer | 1 (3.2) |
| Sub total | 31 (100) |
| Age (year) | |
| Male* | 53.35 ± 11.77 |
| Female* | 52.64 ± 8.54 |
*Data are means ± standard deviations.
MRI parameters of the fast liver MRI scan and conventional liver MRI scan.
| Sequences | Plane | TR (ms) | TE (ms) | Flip angle (degree) | FOV (mm2) | Matrix | Thickness (mm) | No. of slice | Parallel imaging Acceleration factor | Scan time |
|---|---|---|---|---|---|---|---|---|---|---|
| T2W HASTE* | Coronal | 1000 | 97 | 160 | 400 × 340 | 256 × 240 | 6 | 15 | 3 | 15 s |
| T2W FS BLADE* | Axial | 4000** | 79 | 140 | 380 × 380 | 320 × 320 | 6 | 28 | 2 | 2 min, 26 s |
| T2W FS TSE | Axial | 3000 | 100 | 160 | 380 × 285 | 320 × 288 | 6 | 28 | 2 | 1 min |
| DIXON VIBE* | Axial | 3.97 | 1.26/2.49 | 9 | 400× 320 | 320 × 195 | 3 | 64 | 3 | 15 s |
| FS EPI DWI (b = 50, 1000) with 3D diagonal diffusion mode* | Axial | 2200 | 55 | 90 | 395 × 300 | 128 × 96 | 6 | 20 | 2 | 38 s |
| Pre-contrast FS T1 VIBE | Axial | 3.65 | 1.3 | 12 | 400 × 320 | 320 × 195 | 3 | 64 | 3 | 14 s |
| Post-contrast FS T1 VIBE*,# | Axial | 3.65 | 1.3 | 12 | 400 × 320 | 320 × 195 | 3 | 64 | 3 | 14 s |
| Post-contrast FS T1 VIBE | Coronal | 4.21 | 1.35/2.58 | 12 | 450 × 450 | 320 × 288 | 2 | 104 | 6 | 14 s |
*All sequences in the table were used in the conventional liver scan, whereas the items marked with * were used in the abbreviated protocol. For the DWI sequence, b = 50 s/mm2 and 1000 s/mm2 were both acquired in the conventional liver scan, whereas only b = 1000 s/mm2 was acquired in the abbreviated protocol.
**TR is an assumed respiration period of the human adult. The actual TR varied with the actual respiration period of the patients.
#Post-contrast FS T1 VIBE was acquired three times.
Figure 1The sequences used in the abbreviated fast liver MRI protocol and the conventional liver MRI protocol. COR, coronal; AX, axial; in/opp, in-phase and opposed-phase; art, arterial phase; ven, venous phase; del, delayed phase.
Figure 2Sample images acquired with the fast liver workflow of a 74-year-old man with liver metastasis (primary: colon cancer): (A) T2-weighted BLADE; (B) DWI, b = 1000 s/mm2; (C) T2-HASTE; (D, E) in-phase and out-of-phase DIXON VIBE; (F) water images of DIXON VIBE; (G–I) contrast-enhanced T1WI VIBE with arterial-phase (G), venous-phase (H), and delayed-phase (I). The metastasis (arrow) in liver segment VII appeared as slightly high signal intensity on the T2 BLADE and T2 haste image, whereas the hepatic cysts [arrowhead in (A)] in liver segments II and IV show high signal intensity in T2 BLADE. The metastasis is hyperintense in DWI and has low intensity in T1WI. Annular enhancement is visible in the enhanced MR imaging relative to the surrounding liver parenchyma.
Figure 3Sample images acquired with the conventional liver workflow of a 52-year-old post-surgical colon cancer patient. The lesion could not be identified on the T2-weighted BLADE image (A), T2-weighted TSE image (B), DW images with b = 50, 1000 s/mm2 (C, D), pre-contrast T1-weighted Fat-Sat VIBE images (E), or water images of the DIXON VIBE (F). In the arterial phase T1-weighted VIBE (G), multiple small hypervascular focal lesions appear in the right lobe. The suspicious lesions return to isointensity on the venous-phase (H) and delayed-phases (I, J). The diagnostic report from the conventional protocol considered them as transient hepatic intensity difference, whereas in the report from the abbreviated protocol, these suspicious lesions were not mentioned. The abbreviated protocol acquired the image marked with an asterisk (*), whereas the conventional protocol acquired all the series. Notably, the suspicious transient hepatic intensity difference is subtle and difficult to identify.
Distribution of suspicious findings for patients.
| Location of the suspicious findings | No. of data dets | Percentage |
|---|---|---|
| Liver | 48 | 34.5% |
| Renal | 23 | 16.5% |
| Gallbladder | 12 | 8.6% |
| Spleen | 10 | 7.2% |
| Abdominal cavity | 5 | 3.6% |
| Portal vein | 5 | 3.6% |
| Subcapsular area of liver | 4 | 2.9% |
| Lung | 4 | 2.9% |
| Stomach | 3 | 2.2% |
| Pancreas | 2 | 1.4% |
| Peritoneum | 2 | 1.4% |
| Portahepatis | 2 | 1.4% |
| Retroperitoneal space | 2 | 1.4% |
| Vertebra | 2 | 1.4% |
| Retroperitoneal space | 2 | 1.4% |
| Bile ducts | 2 | 1.4% |
| Others* | 11 | 7.9% |
| Total | 139 | 100% |
*Others include those locations that have only one data set. These include adrenal, atrium, hepatic vein, lesser omentum, mesentery, paracaval, perihepatic, thoracic cavity, ureter, subdiaphragm, and vena cava.
Results of concordance analysis between the two liver protocols for the detection of suspicious findings.
| Suspicious findings | No. of concordant pairs | No. of discordant pairs |
|---|---|---|
| Cysts | 32 | 1 |
| Metastasis | 23 | 2 |
| Splenomegaly | 7 | 0 |
| Transient hepatic intensity difference | 6 | 1 |
| Tumor embolus | 6 | 0 |
| Cirrhosis | 5 | 0 |
| Cholecystolithiasis | 5 | 0 |
| Ascites | 5 | 0 |
| Hemangioma | 4 | 0 |
| Lymph node enlargement | 3 | 0 |
| hepatocellular carcinoma (HCC) | 3 | 0 |
| Viable residual tumor tissue of HCC after treatment | 3 | 1 |
| Viable residual tumor tissue of liver metastasis after treatment | 2 | 0 |
| Nodule | 2 | 0 |
| Pneumonia | 2 | 0 |
| Fatty liver | 2 | 0 |
| Chronic cholecystitis | 2 | 0 |
| Cholecystitis | 2 | 0 |
| Bile ducts dilation | 2 | 0 |
| Others* | 18 | 0 |
|
| 134 | 5 |
|
| 96.40% | 3.60% |
*Others include those findings found in only one case. These include adenomyomatosis, atelectasis, cortical adenoma, esophageal-gastric varices, gallbladder enlargement, gastric antrum cancer, gastric retention, hydronephrosis, hydrothorax, hydroureterosis, infarction, pancreatic atrophy, portal, hypertension, renal atrophy, splenculus, thrombus, unviable post-treatment tumor tissue, and vascular malformation.